Jiangsu Wuzhong Pharmaceutical Development Co (SHSE:600200) Total Assets : ¥4,417 Mil (As of Mar. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Jiangsu Wuzhong Pharmaceutical Development Co Total Assets?

Jiangsu Wuzhong Pharmaceutical Development Co's Total Assets for the quarter that ended in Mar. 2024 was ¥4,417 Mil.

During the past 12 months, Jiangsu Wuzhong Pharmaceutical Development Co's average Total Assets Growth Rate was 22.00% per year. During the past 3 years, the average Total Assets Growth Rate was -4.30% per year. During the past 5 years, the average Total Assets Growth Rate was -8.60% per year. During the past 10 years, the average Total Assets Growth Rate was -4.10% per year.

During the past 13 years, Jiangsu Wuzhong Pharmaceutical Development Co's highest 3-Year average Total Assets Growth Rate was 37.10%. The lowest was -13.20%. And the median was 10.00%.

Total Assets is connected with ROA %. Jiangsu Wuzhong Pharmaceutical Development Co's annualized ROA % for the quarter that ended in Mar. 2024 was 0.46%. Total Assets is also linked to Revenue through Asset Turnover. Jiangsu Wuzhong Pharmaceutical Development Co's Asset Turnover for the quarter that ended in Mar. 2024 was 0.16.

Jiangsu Wuzhong Pharmaceutical Development Co Total Assets Historical Data

The historical data trend for Jiangsu Wuzhong Pharmaceutical Development Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Wuzhong Pharmaceutical Development Co Total Assets Chart

Jiangsu Wuzhong Pharmaceutical Development Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

3,919.92

3,705.50

3,758.34

3,909.87

4,326.88

Jiangsu Wuzhong Pharmaceutical Development Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															4,014.49	4,067.61	4,262.28	4,326.88	4,417.30

Jiangsu Wuzhong Pharmaceutical Development Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Jiangsu Wuzhong Pharmaceutical Development Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	1761.444	+	2565.434
	=	4,327

Jiangsu Wuzhong Pharmaceutical Development Co's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	1767.282	+	2650.013
	=	4,417

Jiangsu Wuzhong Pharmaceutical Development Co (SHSE:600200) Total Assets Explanation

Total Assets is connected with ROA %.

Jiangsu Wuzhong Pharmaceutical Development Co's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	20.236	/	( (4326.878	+	4417.295)	/ 2 )
	=	20.236	/	4372.0865
	=	0.46 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Jiangsu Wuzhong Pharmaceutical Development Co's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	703.371	/	( (4326.878	+	4417.295)	/ 2 )
=	703.371	/	4372.0865
=	0.16

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Jiangsu Wuzhong Pharmaceutical Development Co Total Assets Related Terms

Thank you for viewing the detailed overview of Jiangsu Wuzhong Pharmaceutical Development Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Jiangsu Wuzhong Pharmaceutical Development Co (SHSE:600200) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jiangsu Wuzhong Pharmaceutical Development Co Ltd (SHSE:600200) » Definitions » Total Assets

Traded in Other Exchanges

N/A

Address

110 North Road, Soochow 7,8,10 Bank of China Building, Suzhou, Jiangsu, CHN, 215128

Website

http://www.600200.com

Jiangsu Wuzhong Industrial Co Ltd is a China-based company. It develops, produces and sells medicines while engages in real estate development.

Executives

Xu Liang Zhi	senior management
Sun Jian Ying	Supervisors
Zhong Yao Wen	Supervisors
Cheng Xi	senior management
Wu Jian Min	Supervisors
Zhao Wei Yi	Director
Jin Li	Director
Sun Tian Jiang	senior management
Zhu Ju Fang	senior management
Yao Jian Lin	Director
Jin Jian Ping	Supervisors
Li Gui Zhi	Supervisors
Luo Qin	Supervisors
Xia Jian Ping	Director
Zhong Shen Zheng	Director

Jiangsu Wuzhong Pharmaceutical Development Co (SHSE:600200) Headlines

No Headlines